Novel Digital Application for Patients With Acute Leukemia

This study is testing a digital app designed to support patients with acute myeloid leukemia (AML) who are hospitalized and receiving intensive chemotherapy. The app aims to help patients track symptoms, communicate with their care team, and manage their treatment experience. **You may be eligible if...** - You are over 18 and hospitalized with a new or relapsed/refractory diagnosis of AML - You are starting intensive chemotherapy (such as the standard 7+3 regimen) or a low-intensity chemotherapy regimen (hypomethylating agents) - You are able to understand and speak English **You may NOT be eligible if...** - You have acute promyelocytic leukemia (a specific subtype of AML) - You have an active or unstable psychiatric or cognitive condition that prevents app use - You do not speak or understand English Talk to your doctor to see if this trial is right for you.